Octapharma
Clinical trials sponsored by Octapharma, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New shot could help Immune-Compromised patients fight infections Results expected Sep 2026 (estimated)
- New drug aims to stop swelling attacks in hereditary angioedema Results expected Dec 2026 (estimated)
- New hope for rare clotting disorder: drug aims to prevent dangerous clots during surgery and delivery Results expected Dec 2026 (estimated)
- New study tests clotting drug for safer surgery in women with hemophilia a Results expected Feb 2027 (estimated)